| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 58-49-1 | 血管紧张素 | Angiotensin acetate; Alanine,N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-3-phenyl-,L- (6CI,7CI); 1-Asp-5-Val-angiotensin II; 1-L-Asparticacid-5-valine-angiotensin II; 1-a-L-Aspartic acid-5-L-valine-angiotensin II; 11: PN: US20090227507 SEQID:20 unclaimed protein; 11: PN: US6762167 SEQID: 19 unclaimed sequence; 16: PN:WO0144270 SEQID: 19 claimed protein; 178: PN: WO2008004992 SEQID: 42 unclaimedsequence; 17: PN: US20080293634 SEQID: 24 unclaimed sequence; 17: PN: WO0143761SEQID: 19 claimed protein; 17: PN: WO0155176 SEQID: 19 claimed protein; 17: PN:WO02087504 SEQID: 19 claimed protein; 18: PN: WO0002905 SEQID: 19 claimedprotein; 18: PN: WO0198325 SEQID: 19 claimed protein; 19: PN: US20030130196SEQID: 19 claimed protein; 19: PN: WO0056345 SEQID: 19 claimed sequence; 23:PN: WO0069900 SEQID: 672 unclaimed sequence; 23: PN: WO9958140 SEQID: 19 claimedsequence; 24: PN: WO0069900 SEQID: 673 unclaimed sequence; 4: PN: WO0187976PAGE: 16 unclaimed sequence; 5-L-Valine angiotensin II; 5-Valine-angiotensinII; Angiotensin II(Alligator mississippiensis); Angiotensin II (ox); Angiotensin II 5-valine; L-Aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-L-phenylalanine; L-Phenylalanine, N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl-]-L-histidyl]-L-prolyl]-; Valine angiotensin II; [Val5] Angiotensin II, human; |  | C49H70N14O11 | 详情 | 供应商 |
| 20071-00-5 | 醋酸增血压素 | Angiotensin acetate |  | C49H70N14O11.2(C2H4O2) | 详情 | 供应商 |
| 53-73-6 | 增血压素 | Angiotensin II,1-L-asparagine-5-L-valine-; Alanine,N-[1-[N-[N-[N-[N-(N2-L-asparaginyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-3-phenyl-,L- (6CI,7CI); 1-Asn2-5-Val-angiotensin II; 1-Asparagine-5-valineangiotensin II; 1-Asparaginyl-5-valyl-angiotensin II; 1-Aspartic acid-5-valine angiotensin IIamide; 1-Aspartic acid-b-amide 5-valine angiotensin II; 1-L-Asn-5-L-Val-angiotensin II; 1-L-Asparagine-5-L-valineangiotensin II; 1-L-Asparagine-5-L-valine-angiotensin; 1-L-Asparaginyl-5-L-valyl angiotensin octapeptide; 1-a-Asparagine-5-valine-angiotensinII; 12: PN: US20090227507 SEQID: 21 unclaimed protein; 12: PN: US6762167 SEQID:20 unclaimed sequence; 17: PN: WO0144270 SEQID: 20 claimed protein; 18: PN:WO0143761 SEQID: 20 claimed protein; 18: PN: WO0155176 SEQID: 20 claimedprotein; 18: PN: WO02087504 SEQID: 20 claimed protein; 19: PN: WO0002905 SEQID:20 claimed protein; 19: PN: WO0198325 SEQID: 20 claimed protein; 20: PN:US20030130196 SEQID: 20 claimed protein; 20: PN: WO0056345 SEQID: 20 claimedsequence; 24: PN: WO9958140 SEQID: 20 claimed protein; 5-L-Valine-angiotensinII amide; 5-Valine angiotensin II amide; 5-Valine angiotensin II aspartic-b-amide; 5-Valine angiotensinamide II; 5-Valine-angiotensin II-b-amide; 5-Valyl angiotensin II amide; 545: PN: US20090175821 SEQID: 655claimed protein; 6: PN: WO0069900 SEQID: 655 unclaimed sequence; Angiotensin(Ciba); Angiotensin II (Oncorhynchus mykiss); Angiotensin II (eel); AngiotensinII amide; Angiotensin II amide 5-valine; Angiotensin II amide, 5-L-valine-; Angiotensin II aspartic-b-amide, 5-L-valine; Angiotensin II-5-valine-amide; Angiotensin amide; Angiotensin amide, 5-L-valine-; Hypertensin; Hypertensinamide; Hypertensine; Ipertensina; L-Phenylalanine,N-[1-[N-[N-[N-[N-(N2-L-asparaginyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-valyl]-L-histidyl]-L-prolyl]-; NSC 107678; Rainbow trout angiotensin II; Val-Hypertensin-II-asp-b-amide; Val5-angiotensin II amide |  | C49H70N14O11 | 详情 | 供应商 |
| 98112-41-5 | Brevetoxin A; Brevetoxin1; Brevetoxin PbTx 1; GB 1; PbTx 1; Ptychodiscus brevis toxin 1 |  | C49H70O13 | 详情 | 供应商 | |
| 80953-31-7 | Vasopressin,1-(3-mercapto-3-methylbutanoic acid)-2-(O-methyl-L-tyrosine)-8-D-arginine-(9CI); 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane,cyclic peptide deriv. |  | C49H70N14O12S2 | 详情 | 供应商 | |
| 115699-79-1 | Vasopressin,N-L-alanyl-8-L-arginine- (9CI); 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane,cyclic peptide deriv. |  | C49H70N16O13S2 | 详情 | 供应商 | |
| 140430-53-1 | MCA-PRO-LEU-GLY-LEU-DAP(DNP)-ALA-ARG-NH2; MCA-PRO-LEU-GLY-LEU-DAP-ALA-ARG-NH2: MCA-PLGL-DAP-AR-NH2 | MCA-PRO-LEU-GLY-LEU-DAP(DNP)-ALA-ARG-NH2; MOCAC-PRO-LEU-GLY-LEU-[3-DNP-2,3-DAP]-ALA-ARG, AMIDE; MOCAC-PRO-LEU-GLY-LEU-A2PR(DNP)-ALA-ARG-NH2; MOCAC-PRO-LEU-GLY-LEU-N3-[2,4-DINITROPHENYL]-L-2,3-DIAMINOPROPIONYL-ALA-ARG-NH2; MMP-2/MMP-7 SUBSTRATE; MMP-2/MMP-7 SUBSTRATE, FLUOROGENIC; 390 MMP FRET SUBSTRATE I; (7-METHOXYCOUMARIN-4-YL)ACETYL-L-PROLYL-L-LEUCYLGLYCYL-L-LEUCYL-[N-BETA-(2,4-DINITROPHENYL)-L-2,3-DIAMINOPROPIONYL]-L-ALANYL-L-ARGININE AMIDE; 7-METHOXYCOUMARIN-4-ACETYL-PRO-LEU-GLY-LEU-BETA-(2,4-DINITROPHENYLAMINO)ALA-ALA-ARG AMIDE |  | C49H70N14O15 | 详情 | 供应商 |
| 334658-24-1 | 肾上腺素环杷明; 肾上腺素环杷明 | BODIPY CYCLOPAMINE | 无 | C49H70BF2N5O4 | 详情 | 供应商 |
